Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 9, Number 1—January 2003

Research

Cost Effectiveness of a Potential Vaccine for Human papillomavirus

Gillian D. Sanders*Comments to Author  and Al V. Taira*
Author affiliations: *Stanford University, Stanford, California, USA

Main Article

Table 1

Health and economic outcomes of HPV vaccinationa

OutcomeNo vaccinationHPV vaccination
Cost, $
39,682
39,928
Incremental cost, $

246
Life expectancy, yrs
28.785
28.793
Incremental life expectancy, days

2.8
Quality-adjusted life expectancy, yrs
27.720
27.731
Incremental quality-adjusted life expectancy, days

4.0
Incremental cost effectiveness


$/life year

32,066
$/quality-adjusted life year22,755

aHPV, Human papillomavirus.

Main Article

TOP